Thrombin Pathway in 'Trial of PeriOperative Endocrine Therapy Individualising Care' [SUBSTUDY OF 700029612]
Phase of Trial: Phase II
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Anastrozole (Primary) ; Letrozole (Primary) ; Antineoplastics
- Indications Early breast cancer
- Focus Pharmacodynamics
- Acronyms T-POETIC-v1
- 13 Dec 2013 Accrual to date is 87% according to United Kingdom Clinical Research Network.
- 14 Nov 2013 Planned end date changed from 31 Oct 2013 to 31 Dec 2013 as reported by United Kingdom Clinical Research Network record.
- 13 Nov 2013 Accrual to date is 82% according to United Kingdom Clinical Research Network.